Over the past 12 months, Longeveron insiders made no open-market purchases or sales of the stock.
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Joshua Hare | Chief Scientific Officer | 450,374 | 0 | 450,374 | 40.5% | 21 Aug, 2026 |
| 2 | Donald M Soffer | Director | 66,937 | 70,242 | 137,179 | 12.3% | 19 May, 2022 |
| 3 | Paul T Lehr | General Counsel, Secretary | 86,829 | 0 | 86,829 | 7.8% | 05 Oct, 2026 |
| 4 | Stephen H Willard | Chief Executive Officer | 74,916 | 0 | 74,916 | 6.7% | 05 Oct, 2026 |
| 5 | Nataliya Agafonova | Chief Medical Officer | 68,986 | 0 | 68,986 | 6.2% | 05 Oct, 2026 |
| 6 | Devin Blass | Cto Svp Of Cmc | 68,653 | 0 | 68,653 | 6.2% | 05 Oct, 2026 |
| 7 | Lisa Locklear | Chief Financial Officer | 44,686 | 0 | 44,686 | 4.0% | 06 Jul, 2026 |
| 8 | Mohamed Wa'El Ahmed Hashad | Chief Executive Officer | 43,413 | 0 | 43,413 | 3.9% | 17 Jul, 2025 |
| 9 | Rock Soffer | Director | 39,950 | 0 | 39,950 | 3.6% | 21 Aug, 2026 |
| 10 | Nirav S. Jhaveri | Chief Financial Officer | 29,258 | 0 | 29,258 | 2.6% | 05 Oct, 2026 |
| 11 | James Nathaniel Powell | Chief Executive Officer | 12,559 | 0 | 12,559 | 1.1% | 06 Jan, 2026 |
| 12 | Ursula Ungaro | Director | 7,700 | 0 | 7,700 | 0.7% | 21 Aug, 2026 |
| 13 | George A. Jr. Paletta | Director | 7,000 | 0 | 7,000 | 0.6% | 21 Aug, 2026 |
| 14 | Roger Joseph Hajjar | Director | 6,900 | 0 | 6,900 | 0.6% | 21 Aug, 2026 |
| 15 | Khoso Baluch | Director | 6,739 | 0 | 6,739 | 0.6% | 13 Aug, 2025 |
| 16 | Leah Rush Cann | Director | 3,600 | 0 | 3,600 | 0.3% | 21 Aug, 2026 |
| 17 | Arjun Jj Desai | Director | 3,600 | 0 | 3,600 | 0.3% | 21 Aug, 2026 |
| 18 | Deborah Ascheim | Director | 3,600 | 0 | 3,600 | 0.3% | 21 Aug, 2026 |
| 19 | Neha J. Motwani | Director | 3,300 | 0 | 3,300 | 0.3% | 17 Jul, 2025 |
| 20 | Richard N Kender | Director | 3,300 | 0 | 3,300 | 0.3% | 17 Jul, 2025 |
| 21 | Kwan-Hong Christopher Min | Chief Medical Officer | 3,043 | 0 | 3,043 | 0.3% | 12 Apr, 2022 |
| 22 | Neil E Hare | Director | 2,935 | 0 | 2,935 | 0.3% | 19 Aug, 2024 |
| 23 | Geoff Green | Ceo | 2,696 | 0 | 2,696 | 0.2% | 08 Apr, 2022 |
| 24 | James Clavijo | Cfo And Treasurer | 1,269 | 0 | 1,269 | 0.1% | 29 Jun, 2023 |
| 25 | Jeffrey Pfeffer | Director | 150 | 0 | 150 | 0.0% | 29 Dec, 2023 |
| 26 | Cathy Ross | Director | 100 | 0 | 100 | 0.0% | 11 Jan, 2024 |
| 27 | Todd C Girolamo | Director | 50 | 0 | 50 | 0.0% | 25 Feb, 2022 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 01 Oct, 2026 | Nataliya Agafonova | Chief Medical Officer | Disposed F | 2,913 | $2.59 | $7.54K | 68,778 | Direct |
| 01 Oct, 2026 | Devin Blass | Cto Svp Of Cmc | Disposed F | 2,520 | $2.59 | $6.53K | 68,653 | Direct |
| 01 Oct, 2026 | Stephen H Willard | Chief Executive Officer | Disposed F | 1,987 | $2.59 | $5.15K | 74,916 | Direct |
| 01 Oct, 2026 | Paul T Lehr | General Counsel, Secretary | Disposed F | 2,253 | $2.59 | $5.84K | 83,889 | Direct |
| 01 Oct, 2026 | Nirav S. Jhaveri | Chief Financial Officer | Disposed F | 742 | $2.59 | $1.92K | 29,258 | Direct |
| 17 Aug, 2026 | Nirav S. Jhaveri | Chief Financial Officer | Acquired A | 300,000 | $0.00 | $0 | 30,000 | Direct |
| 19 Aug, 2026 | Leah Rush Cann | Director | Acquired A | 36,000 | $0.00 | $0 | 3,600 | Direct |
| 19 Aug, 2026 | Devin Blass | Cto Svp Of Cmc | Acquired A | 286,000 | $0.00 | $0 | 71,174 | Direct |
| 19 Aug, 2026 | Paul T Lehr | General Counsel, Secretary | Acquired A | 286,000 | $0.00 | $0 | 86,142 | Direct |
| 19 Aug, 2026 | Rock Soffer | Director | Acquired A | 36,000 | $0.00 | $0 | 26,203 | Direct |
| 19 Aug, 2026 | Ursula Ungaro | Director | Acquired A | 36,000 | $0.00 | $0 | 7,700 | Direct |
| 19 Aug, 2026 | Deborah Ascheim | Director | Acquired A | 36,000 | $0.00 | $0 | 3,600 | Direct |
| 19 Aug, 2026 | George A. Jr. Paletta | Director | Acquired A | 36,000 | $0.00 | $0 | 7,000 | Direct |
| 19 Aug, 2026 | Nataliya Agafonova | Chief Medical Officer | Acquired A | 286,000 | $0.00 | $0 | 71,691 | Direct |
| 19 Aug, 2026 | Arjun Jj Desai | Director | Acquired A | 36,000 | $0.00 | $0 | 3,600 | Direct |
| 19 Aug, 2026 | Joshua Hare | Chief Scientific Officer | Acquired A | 286,000 | $0.00 | $0 | 160,780 | Direct |
| 19 Aug, 2026 | Roger Joseph Hajjar | Director | Acquired A | 36,000 | $0.00 | $0 | 6,900 | Direct |
| 06 Jul, 2026 | Joshua Hare | Chief Scientific Officer | Acquired A | 600,000 | $0.00 | $0 | 132,180 | Direct |
| 06 Jul, 2026 | Joshua Hare | Chief Scientific Officer | Acquired A | 400,000 | $0.00 | $0 | 40,000 | Direct |
| 01 Jul, 2026 | Stephen H Willard | Chief Executive Officer | Disposed F | 18,046 | $7.29 | $131.57K | 77,168 | Direct |